Cover Image
市場調查報告書

自體免疫疾病診斷設備:醫療設備的開發平台評估

Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015

出版商 GlobalData 商品編碼 351353
出版日期 內容資訊 英文 295 Pages
訂單完成後即時交付
價格
Back to Top
自體免疫疾病診斷設備:醫療設備的開發平台評估 Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015
出版日期: 2016年01月05日 內容資訊: 英文 295 Pages
簡介

本報告提供自體免疫疾病診斷設備的開發中產品相關調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的最近事件等資訊。

第1章 目錄

第2章 簡介

  • 自體免疫疾病 概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:地區 (國家) 別
  • 開發中產品:法規途徑別
  • 開發中產品:核准時期別 (估計)

第4章 自體免疫疾病診斷設備 - 正在開發的開發中產品:各企業

  • 開發企業 - 開發中產品:各開發階段
  • 開發中產品:各開發階段

第5章 自體免疫疾病診斷設備的開發企業與產品概要

  • Adaptive Biotechnologies Corporation
  • Agena Bioscience, Inc
  • Albert-Ludwigs-Universitat Freiburg
  • Alere Inc.
  • Amarantus Bioscience Holdings, Inc.
  • Amdix B.V.
  • Analyticon Biotechnologies AG
  • apDia n.v.
  • Autoimmune Technologies, LLC
  • Beckman Coulter, Inc.
  • BG Medicine, Inc.
  • Biocortech
  • Biogen, Inc.
  • Biomedal S.L.
  • Biomerica, Inc.
  • Bionure Farma, S.L.
  • Bio-Rad Laboratories, Inc.
  • BioRap Technologies Ltd.
  • Boston University
  • CareDx, Inc.
  • CD Diagnostics, Inc.
  • Chronix Biomedical, Inc.
  • Co-Diagnostics HBDC, Inc.
  • Crescendo Bioscience, Inc.
  • Digna Biotech, S.L.
  • Durin Technologies, Inc.
  • Enterome Bioscience SA
  • Ezose Sciences Inc.
  • Flamentera AG
  • Genalyte, Inc.
  • Genentech, Inc.
  • GeNeuro SA
  • Glycominds Ltd.
  • Grifols, S.A.
  • Hannover Medical School
  • Helmholtz Centre for Infection Research
  • HOB Biotech Group Co., Ltd.
  • Hospital for Special Surgery
  • Hycor Biomedical Inc.
  • Ignyta, Inc.
  • ImmusanT, Inc.
  • Innobiochips
  • INOVA Diagnostics, Inc.
  • Institut National de la Sante et de la Recherche Medicale
  • Is Diagnostics
  • LineaGen, Inc.
  • Lophius Biosciences GmbH
  • Louisville Bioscience, Inc.
  • Max-Delbruck-Centrum fur Molekulare Medizin (MDC)
  • Medica Corporation
  • Metabolomic Technologies Inc.
  • Metanomics Health GmbH
  • MSDx, Inc.
  • Myriad Genetics, Inc.
  • Nanosphere, Inc.
  • Neuro Vigor, LLC
  • Northwestern University
  • NoToPharm s.r.l.
  • NOWDiagnostics
  • OmniBiome Therapeutics Inc.
  • One Way Liver Genomics, S.L.
  • OPKO Health, Inc.
  • Oxford Gene Technology Limited
  • Oxford Immunotec Limited
  • Pediatric Bioscience, LLC
  • Progentec Diagnostics, Inc.
  • Protagen AG
  • ProteinLogic Ltd
  • Quanterix Corporation
  • Regulus Therapeutics Inc.
  • Rice University
  • Roche Diagnostics International Ltd.
  • Shuwen Biotech Co. Ltd.
  • Singulex, Inc.
  • SomaLogic, Inc.
  • Southern Illinois University Carbondale
  • SQI Diagnostics Inc.
  • The Johns Hopkins University
  • The Walter and Eliza Hall Institute of Medical Research
  • TheraDiag SA
  • Thermo Fisher Scientific Inc.
  • Toscana Biomarkers Srl
  • Univalue Valorizacion, S.L.
  • University of California, San Francisco
  • University of Chicago
  • University of Colorado
  • University of Florida
  • University of Manchester
  • University of Oxford
  • University of Pecs
  • University Rovira i Virgili
  • US Biomarkers, Inc.
  • Washington University in St. Louis
  • XAir Diagnostics B.V.
  • XEPTAGEN SpA
  • Yale University

第6章 自體免疫疾病診斷設備 - 最近的事件

第7章 附錄

目錄
Product Code: GDME0148EPD

GlobalData's Medical Devices sector report, "Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015" provides an overview of Auto-Immune Diseases currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Auto-Immune Diseases pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Auto-Immune Diseases under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Auto-Immune Diseases and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Auto-Immune Diseases under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Auto-Immune Diseases Overview

3. Products under Development

  • 3.1. Auto-Immune Diseases - Pipeline Products by Stage of Development
  • 3.2. Auto-Immune Diseases - Pipeline Products by Territory
  • 3.3. Auto-Immune Diseases - Pipeline Products by Regulatory Path
  • 3.4. Auto-Immune Diseases - Pipeline Products by Estimated Approval Date

4. Auto-Immune Diseases - Pipeline Products under Development by Companies

  • 4.1. Auto-Immune Diseases Companies - Pipeline Products by Stage of Development
  • 4.2. Auto-Immune Diseases - Pipeline Products by Stage of Development

5. Auto-Immune Diseases Companies and Product Overview

  • 5.1. Adaptive Biotechnologies Corporation Company Overview
    • 5.1.1. Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Agena Bioscience, Inc Company Overview
    • 5.2.1. Agena Bioscience, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Albert-Ludwigs-Universitat Freiburg Company Overview
    • 5.3.1. Albert-Ludwigs-Universitat Freiburg Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Alere Inc. Company Overview
    • 5.4.1. Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Amarantus Bioscience Holdings, Inc. Company Overview
    • 5.5.1. Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Amdix B.V. Company Overview
    • 5.6.1. Amdix B.V. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Analyticon Biotechnologies AG Company Overview
    • 5.7.1. Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. apDia n.v. Company Overview
    • 5.8.1. apDia n.v. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Autoimmune Technologies, LLC Company Overview
    • 5.9.1. Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Beckman Coulter, Inc. Company Overview
    • 5.10.1. Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. BG Medicine, Inc. Company Overview
    • 5.11.1. BG Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Biocortech Company Overview
    • 5.12.1. Biocortech Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Biogen, Inc. Company Overview
    • 5.13.1. Biogen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Biomedal S.L. Company Overview
    • 5.14.1. Biomedal S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Biomerica, Inc. Company Overview
    • 5.15.1. Biomerica, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Bionure Farma, S.L. Company Overview
    • 5.16.1. Bionure Farma, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Bio-Rad Laboratories, Inc. Company Overview
    • 5.17.1. Bio-Rad Laboratories, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. BioRap Technologies Ltd. Company Overview
    • 5.18.1. BioRap Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Boston University Company Overview
    • 5.19.1. Boston University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. CareDx, Inc. Company Overview
    • 5.20.1. CareDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. CD Diagnostics, Inc. Company Overview
    • 5.21.1. CD Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Chronix Biomedical, Inc. Company Overview
    • 5.22.1. Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Co-Diagnostics HBDC, Inc. Company Overview
    • 5.23.1. Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Crescendo Bioscience, Inc. Company Overview
    • 5.24.1. Crescendo Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Digna Biotech, S.L. Company Overview
    • 5.25.1. Digna Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. Durin Technologies, Inc. Company Overview
    • 5.26.1. Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Enterome Bioscience SA Company Overview
    • 5.27.1. Enterome Bioscience SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. Ezose Sciences Inc. Company Overview
    • 5.28.1. Ezose Sciences Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. Flamentera AG Company Overview
    • 5.29.1. Flamentera AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Genalyte, Inc. Company Overview
    • 5.30.1. Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. Genentech, Inc. Company Overview
    • 5.31.1. Genentech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. GeNeuro SA Company Overview
    • 5.32.1. GeNeuro SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. Glycominds Ltd. Company Overview
    • 5.33.1. Glycominds Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. Grifols, S.A. Company Overview
    • 5.34.1. Grifols, S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. Hannover Medical School Company Overview
    • 5.35.1. Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. Helmholtz Centre for Infection Research Company Overview
    • 5.36.1. Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. HOB Biotech Group Co., Ltd. Company Overview
    • 5.37.1. HOB Biotech Group Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38. Hospital for Special Surgery Company Overview
    • 5.38.1. Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39. Hycor Biomedical Inc. Company Overview
    • 5.39.1. Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40. Ignyta, Inc. Company Overview
    • 5.40.1. Ignyta, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41. ImmusanT, Inc. Company Overview
    • 5.41.1. ImmusanT, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42. Innobiochips Company Overview
    • 5.42.1. Innobiochips Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43. INOVA Diagnostics, Inc. Company Overview
    • 5.43.1. INOVA Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44. Institut National de la Sante et de la Recherche Medicale Company Overview
    • 5.44.1. Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45. Is Diagnostics Company Overview
    • 5.45.1. Is Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46. LineaGen, Inc. Company Overview
    • 5.46.1. LineaGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47. Lophius Biosciences GmbH Company Overview
    • 5.47.1. Lophius Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48. Louisville Bioscience, Inc. Company Overview
    • 5.48.1. Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49. Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Company Overview
    • 5.49.1. Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50. Medica Corporation Company Overview
    • 5.50.1. Medica Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.51. Metabolomic Technologies Inc. Company Overview
    • 5.51.1. Metabolomic Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.52. Metanomics Health GmbH Company Overview
    • 5.52.1. Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.53. MSDx, Inc. Company Overview
    • 5.53.1. MSDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.54. Myriad Genetics, Inc. Company Overview
    • 5.54.1. Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.55. Nanosphere, Inc. Company Overview
    • 5.55.1. Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.56. Neuro Vigor, LLC Company Overview
    • 5.56.1. Neuro Vigor, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.57. Northwestern University Company Overview
    • 5.57.1. Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.58. NoToPharm s.r.l. Company Overview
    • 5.58.1. NoToPharm s.r.l. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.59. NOWDiagnostics Company Overview
    • 5.59.1. NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.60. OmniBiome Therapeutics Inc. Company Overview
    • 5.60.1. OmniBiome Therapeutics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.61. One Way Liver Genomics, S.L. Company Overview
    • 5.61.1. One Way Liver Genomics, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.62. OPKO Health, Inc. Company Overview
    • 5.62.1. OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.63. Oxford Gene Technology Limited Company Overview
    • 5.63.1. Oxford Gene Technology Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.64. Oxford Immunotec Limited Company Overview
    • 5.64.1. Oxford Immunotec Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.65. Pediatric Bioscience, LLC Company Overview
    • 5.65.1. Pediatric Bioscience, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.66. Progentec Diagnostics, Inc. Company Overview
    • 5.66.1. Progentec Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.67. Protagen AG Company Overview
    • 5.67.1. Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.68. ProteinLogic Ltd Company Overview
    • 5.68.1. ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.69. Quanterix Corporation Company Overview
    • 5.69.1. Quanterix Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.70. Regulus Therapeutics Inc. Company Overview
    • 5.70.1. Regulus Therapeutics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.71. Rice University Company Overview
    • 5.71.1. Rice University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.72. Roche Diagnostics International Ltd. Company Overview
    • 5.72.1. Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.73. Shuwen Biotech Co. Ltd. Company Overview
    • 5.73.1. Shuwen Biotech Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.74. Singulex, Inc. Company Overview
    • 5.74.1. Singulex, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.75. SomaLogic, Inc. Company Overview
    • 5.75.1. SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.76. Southern Illinois University Carbondale Company Overview
    • 5.76.1. Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview
  • 5.77. SQI Diagnostics Inc. Company Overview
    • 5.77.1. SQI Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.78. The Johns Hopkins University Company Overview
    • 5.78.1. The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.79. The Walter and Eliza Hall Institute of Medical Research Company Overview
    • 5.79.1. The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview
  • 5.80. TheraDiag SA Company Overview
    • 5.80.1. TheraDiag SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.81. Thermo Fisher Scientific Inc. Company Overview
    • 5.81.1. Thermo Fisher Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.82. Toscana Biomarkers Srl Company Overview
    • 5.82.1. Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview
  • 5.83. Univalue Valorizacion, S.L. Company Overview
    • 5.83.1. Univalue Valorizacion, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.84. University of California, San Francisco Company Overview
    • 5.84.1. University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview
  • 5.85. University of Chicago Company Overview
    • 5.85.1. University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
  • 5.86. University of Colorado Company Overview
    • 5.86.1. University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
  • 5.87. University of Florida Company Overview
    • 5.87.1. University of Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.88. University of Manchester Company Overview
    • 5.88.1. University of Manchester Pipeline Products & Ongoing Clinical Trials Overview
  • 5.89. University of Oxford Company Overview
    • 5.89.1. University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
  • 5.90. University of Pecs Company Overview
    • 5.90.1. University of Pecs Pipeline Products & Ongoing Clinical Trials Overview
  • 5.91. University Rovira i Virgili Company Overview
    • 5.91.1. University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview
  • 5.92. US Biomarkers, Inc. Company Overview
    • 5.92.1. US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.93. Washington University in St. Louis Company Overview
    • 5.93.1. Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview
  • 5.94. XAir Diagnostics B.V. Company Overview
    • 5.94.1. XAir Diagnostics B.V. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.95. XEPTAGEN SpA Company Overview
    • 5.95.1. XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.96. Yale University Company Overview
    • 5.96.1. Yale University Pipeline Products & Ongoing Clinical Trials Overview

6. Auto-Immune Diseases- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Auto-Immune Diseases - Pipeline Products by Stage of Development
  • Table 2: Auto-Immune Diseases - Pipeline Products by Territory
  • Table 3: Auto-Immune Diseases - Pipeline Products by Regulatory Path
  • Table 4: Auto-Immune Diseases - Pipeline Products by Estimated Approval Date
  • Table 5: Auto-Immune Diseases Companies - Pipeline Products by Stage of Development
  • Table 6: Auto-Immune Diseases - Pipeline Products by Stage of Development
  • Table 7: Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: Diagnostic Test - Auto-Immune Disease - Product Status
  • Table 9: Diagnostic Test - Auto-Immune Disease - Product Description
  • Table 10: Agena Bioscience, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 11: AttoSense Lupus Panel - Product Status
  • Table 12: AttoSense Lupus Panel - Product Description
  • Table 13: Albert-Ludwigs-Universitat Freiburg Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: Biomarker Based Assay - Systemic Sclerosis - Product Status
  • Table 15: Biomarker Based Assay - Systemic Sclerosis - Product Description
  • Table 16: Mitochondrial DNA Based Assay - Autoimmune and Autoinflammatory Diseases - Product Status
  • Table 17: Mitochondrial DNA Based Assay - Autoimmune and Autoinflammatory Diseases - Product Description
  • Table 18: Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: AIMS System - Cardiolipin IgG Test - Product Status
  • Table 20: AIMS System - Cardiolipin IgG Test - Product Description
  • Table 21: AtheNA Multi-Lyte System - Cardiolipin IgG Test - Product Status
  • Table 22: AtheNA Multi-Lyte System - Cardiolipin IgG Test - Product Description
  • Table 23: Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Diagnostic Assay - Neuromyelitis Optica - Product Status
  • Table 25: Diagnostic Assay - Neuromyelitis Optica - Product Description
  • Table 26: Diagnostic Assay - Paraneoplastic Disease - Product Status
  • Table 27: Diagnostic Assay - Paraneoplastic Disease - Product Description
  • Table 28: Amdix B.V. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Chitotriosidase Biomarker - Mutiple Sclerosis - Product Status
  • Table 30: Chitotriosidase Biomarker - Mutiple Sclerosis - Product Description
  • Table 31: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Turbitex IgA - Product Status
  • Table 33: Turbitex IgA - Product Description
  • Table 34: apDia n.v. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Diagnostic Test - MS - Product Status
  • Table 36: Diagnostic Test - MS - Product Description
  • Table 37: Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Anti-Squalene Antibody Assay - Product Status
  • Table 39: Anti-Squalene Antibody Assay - Product Description
  • Table 40: Autoimmune Disease Virus Assay - Graves' Disease - Product Status
  • Table 41: Autoimmune Disease Virus Assay - Graves' Disease - Product Description
  • Table 42: Autoimmune Disease Virus Assay - Juvenile Rheumatoid Arthritis - Product Status
  • Table 43: Autoimmune Disease Virus Assay - Juvenile Rheumatoid Arthritis - Product Description
  • Table 44: Autoimmune Disease Virus Assay - Sjogren Syndrome - Product Status
  • Table 45: Autoimmune Disease Virus Assay - Sjogren Syndrome - Product Description
  • Table 46: Autoimmune Disease Virus Assay - Systemic Lupus Erythematosus - Product Status
  • Table 47: Autoimmune Disease Virus Assay - Systemic Lupus Erythematosus - Product Description
  • Table 48: Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: SYNCHRON LXi 725 Anti-dsDNA Assay - Product Status
  • Table 50: SYNCHRON LXi 725 Anti-dsDNA Assay - Product Description
  • Table 51: SYNCHRON LXi 725 IL-6 Assay - Product Status
  • Table 52: SYNCHRON LXi 725 IL-6 Assay - Product Description
  • Table 53: BG Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Diagnostic Assay - Multiple Sclerosis - Product Status
  • Table 55: Diagnostic Assay - Multiple Sclerosis - Product Description
  • Table 56: Biocortech Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Blood Test - Cognitive Deficits - Product Status
  • Table 58: Blood Test - Cognitive Deficits - Product Description
  • Table 59: Biogen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Companion Diagnostic Test - Sjogren's Syndrome - Product Status
  • Table 61: Companion Diagnostic Test - Sjogren's Syndrome - Product Description
  • Table 62: Biomedal S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 63: ELISA DELIAC GFD - Product Status
  • Table 64: ELISA DELIAC GFD - Product Description
  • Table 65: IVYLISA DGP8 - Product Status
  • Table 66: IVYLISA DGP8 - Product Description
  • Table 67: Stick DELIAC GFD - Product Status
  • Table 68: Stick DELIAC GFD - Product Description
  • Table 69: Biomerica, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 70: Anti-Gliadin IgA Elisa Kit - Product Status
  • Table 71: Anti-Gliadin IgA Elisa Kit - Product Description
  • Table 72: Anti-Gliadin IgG Elisa Kit - Product Status
  • Table 73: Anti-Gliadin IgG Elisa Kit - Product Description
  • Table 74: Transglutaminase Elisa Kit - Product Status
  • Table 75: Transglutaminase Elisa Kit - Product Description
  • Table 76: Bionure Farma, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: BN - 301 Diagnostic/Prognostic Test - Product Status
  • Table 78: BN - 301 Diagnostic/Prognostic Test - Product Description
  • Table 79: Bio-Rad Laboratories, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 80: EVOLIS - Autoimmune Panel - Product Status
  • Table 81: EVOLIS - Autoimmune Panel - Product Description
  • Table 82: BioRap Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 83: Biomarker Test - Multiple Sclerosis - Product Status
  • Table 84: Biomarker Test - Multiple Sclerosis - Product Description
  • Table 85: Boston University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 86: Blood-Based Diagnostic Test - Nephropathy - Product Status
  • Table 87: Blood-Based Diagnostic Test - Nephropathy - Product Description
  • Table 88: CareDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 89: Diagnostic Test - Crohn's Disease - Product Status
  • Table 90: Diagnostic Test - Crohn's Disease - Product Description
  • Table 91: CD Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 92: Cygnasure Diagnostic Immunoassay - Lupus - Product Status
  • Table 93: Cygnasure Diagnostic Immunoassay - Lupus - Product Description
  • Table 94: Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 95: Companion Diagnostic Test - Multiple Sclerosis - Product Status
  • Table 96: Companion Diagnostic Test - Multiple Sclerosis - Product Description
  • Table 97: Companion Diagnostic Test - Systemic Lupus Erythematous - Product Status
  • Table 98: Companion Diagnostic Test - Systemic Lupus Erythematous - Product Description
  • Table 99: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 100: Diagnostic Test - Auto-immune Disorder - Product Status
  • Table 101: Diagnostic Test - Auto-immune Disorder - Product Description
  • Table 102: Crescendo Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 103: Multi-Biomarker Test - Ankylosing Spondylitis - Product Status
  • Table 104: Multi-Biomarker Test - Ankylosing Spondylitis - Product Description
  • Table 105: Multi-Biomarker Test - Psoriatic Arthritis - Product Status
  • Table 106: Multi-Biomarker Test - Psoriatic Arthritis - Product Description
  • Table 107: Multi-Biomarker Test - Systemic Lupus Erythematosus - Product Status
  • Table 108: Multi-Biomarker Test - Systemic Lupus Erythematosus - Product Description
  • Table 109: Digna Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 110: Anti-CD-137 Antibodies Assay - Product Status
  • Table 111: Anti-CD-137 Antibodies Assay - Product Description
  • Table 112: MTA - Multiple Sclerosis Assay - Product Status
  • Table 113: MTA - Multiple Sclerosis Assay - Product Description
  • Table 114: Prognostic Test - Multiple Sclerosis - Product Status
  • Table 115: Prognostic Test - Multiple Sclerosis - Product Description
  • Table 116: Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 117: Diagnostic Test - Parkinson's Disease - Product Status
  • Table 118: Diagnostic Test - Parkinson's Disease - Product Description
  • Table 119: Enterome Bioscience SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 120: Diagnostic Test - Multiple Sclerosis - Product Status
  • Table 121: Diagnostic Test - Multiple Sclerosis - Product Description
  • Table 122: Diagnostic Test - Type 2 Diabetes - Product Status
  • Table 123: Diagnostic Test - Type 2 Diabetes - Product Description
  • Table 124: Ezose Sciences Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 125: Biomarker Diagnostic Assay - Multiple Sclerosis - Product Status
  • Table 126: Biomarker Diagnostic Assay - Multiple Sclerosis - Product Description
  • Table 127: Flamentera AG Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

  • Figure 1: Auto-Immune Diseases - Pipeline Products by Stage of Development
  • Figure 2: Auto-Immune Diseases - Pipeline Products by Territory
  • Figure 3: Auto-Immune Diseases - Pipeline Products by Regulatory Path
  • Figure 4: Auto-Immune Diseases - Pipeline Products by Estimated Approval Date
Back to Top